Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gatifloxacin pentahydrate

Gatifloxacin pentahydrate

US Patent 6413969 · Granted Jul 2, 2002

Estimated economic value: $48,706,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2025
Systems, devices, and methods for separating and washing microorganisms2025
Wearable health monitors and methods of monitoring health2023
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2023
Wearable health monitors and methods of monitoring health2021
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2021
Body stretching bar2021
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2020
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2018
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2018
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic ac2017
Crystal structures of SGLT2 inhibitors and processes for preparing same2016